A Randomized Double Blind Placebo Controlled Proof of Concept Study to Evaluate Safety, Tolerability and Efficacy of Daily Oral THX-110 in Treating Adults With Tourette Syndrome ("Entourage")
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2019
Price : $35 *
At a glance
- Drugs Dronabinol/palmitoylethanolamide (Primary)
- Indications Gilles de la Tourette's syndrome
- Focus Proof of concept; Therapeutic Use
- Sponsors Therapix Biosciences
- 24 Sep 2019 Status changed from not yet recruiting to discontinued.
- 24 Sep 2019 Planned End Date changed to 29 Jul 2019.
- 06 Sep 2018 New trial record